Skip to content
OpenCapital
Get started

MiMedx Group MDXG EBITDA

EBITDA at other companies

IAR
Integra LifeSciencesIART
$53.68M+111%
Vericel logo
VericelVCEL
-$4.8M+52.5%
Enovis logo
EnovisENOV
$79.89M+224%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$105K+104%
Solventum logo
SolventumSOLV
——
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
——

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

−$16.0Mebit+
$301.0KDepreciation Depletion & Amortization
=-$15.75M

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's EBITDA?
MiMedx Group (MDXG) reported EBITDA of -$15.75M in Q1 2026.
How has MiMedx Group's EBITDA changed year-over-year?
MiMedx Group's EBITDA decreased by 231.5% year-over-year, from $11.97M to -$15.75M.
What is the long-term trend for MiMedx Group's EBITDA?
Over 3 years (2021 to 2025), MiMedx Group's EBITDA has grown at a 192.3% compound annual growth rate (CAGR), from -$3.15M to $78.77M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.